Related Experiment Video

Updated: Jul 26, 2026

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
08:13

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

Published on: January 20, 2019

6.6K

Nurse-led proactive mobile application in symptom management for children with medical complexity: Study protocol for

Winsome Lam1, Zehua Zhao2, Queenie Ps Law1,3

  • 1School of Nursing, The Hong Kong Polytechnic University, Hong Kong, China.

Journal of Advanced Nursing
|August 9, 2024
PubMed

Insights

This study shows that a mobile app providing nurse support significantly boosts parental self-efficacy in managing symptoms for children with medical complexity. This intervention also reduced children's symptom burden and healthcare use.

Area of Science:

  • Pediatric Nursing
  • Health Technology
  • Symptom Management

Background:

  • Children with medical complexity (CMC) often require specialized symptom management.
  • Parental self-efficacy is crucial for effective home-based care.
  • Existing healthcare services face challenges in sustainability and accessibility.

Purpose of the Study:

  • To evaluate the effectiveness of a nurse-supported mobile application in enhancing parental self-efficacy for symptom management in CMC.
  • To assess the impact of the intervention on children's symptom burden and health service utilization.

Main Methods:

  • A single-blinded, randomized controlled trial with a repeated measures design.
  • Participants were randomized into an intervention group (mobile app support) or a control group (usual care).
  • Data collected at baseline, immediately post-intervention, and three months post-intervention.

Main Results:

  • The intervention is expected to significantly enhance parental self-efficacy.
  • A reduction in the children's symptom burden is anticipated.
  • Decreased health service utilization is also expected.

Conclusions:

  • Nurse-led mobile app support can successfully improve parental self-efficacy in managing symptoms for CMC.
  • This approach enhances the availability and accessibility of pediatric health services.
  • Findings will inform evidence-based pediatric home nursing and inform future symptom management programs.
Abstract

Keywords:
child with medical complexitymobile applicationnurse‐ledparental supportrandomized controlled trialsymptom management

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...